Legofer

Iron Protein Succinylate, the active ingredient in Legofer, is a iron supplement presented as an oral dosage form for oral use. It provides elemental iron to treat iron deficiency anemia in patients requiring iron repletion.

GNH USA supplies Legofer as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Legofer is an oral iron supplement that addresses disorders of iron metabolism and related anemia. - Iron deficiency anemia: restores normal hemoglobin and ferritin levels, alleviating fatigue and weakness. - Anemia of chronic kidney disease: supports erythropoiesis when endogenous iron stores are insufficient. - Post‑surgical blood loss anemia: replenishes iron lost during operative procedures to promote recovery.

Legofer may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Constipation: reduced bowel movements. - Abdominal discomfort: cramping or pain. - Darkened stools: harmless change in stool color. - Metallic taste: transient alteration in taste perception. - Diarrhea: loose stools in some individuals.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or anaphylaxis. - Iron overload: excessive iron accumulation with long‑term misuse. - Significant gastrointestinal bleeding: rare but potentially serious. - Hypotension: low blood pressure after rapid absorption. - Hemolysis: destruction of red blood cells in susceptible patients. - Acute iron toxicity: occurs with accidental overdose.

Before initiating therapy with Legofer, several safety considerations should be observed. - Assess iron status: confirm deficiency with laboratory tests before prescribing. - Monitor hemoglobin: periodic checks to evaluate response and avoid excess. - Hypersensitivity: discontinue if signs of allergic reaction appear. - Gastrointestinal disorders: use cautiously in patients with IBD or ulcer disease. - Pregnancy and lactation: evaluate risk‑benefit ratio; consult obstetric guidance. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Legofer can affect the absorption or efficacy of several concomitant medicines.

Major Interactions (Avoid): - Tetracycline antibiotics: chelation reduces absorption of both agents. - Levothyroxine: iron interferes with thyroid hormone uptake. - Bisphosphonates: concurrent intake diminishes oral bioavailability. - Quinolone antibiotics: reduced antimicrobial effectiveness. - Calcium supplements: competitive inhibition of iron absorption.

Moderate Interactions (Monitor Closely): - Proton pump inhibitors: decreased gastric acidity may lower iron uptake. - Antacids containing magnesium or aluminum: can bind iron and limit absorption. - Foods high in phytates (e.g., legumes, whole grains): may reduce iron bioavailability. - Oral contraceptives: monitor for altered iron parameters. - Certain diuretics (e.g., thiazides): watch for electrolyte shifts when combined with iron therapy.